Post-COVID-19 Syndrome Clinical Trial
Official title:
Impact of Vagus Nerve Stimulation on Post-Aerobic Activity Recovery in Post Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients
NCT number | NCT05764070 |
Other study ID # | SARS-CoV-2 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 9, 2023 |
Est. completion date | August 4, 2023 |
Verified date | August 2023 |
Source | Istanbul Medipol University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Chronic fatigue, weakness, dyspnea, headaches, cognitive dysfunction, stress, sadness, anxiety, sleep disturbances, and orthostatic intolerance are among the symptoms of acute Covid-19 in patients, and these symptoms persist for more than 12 weeks after recovery. Extended Covid-19 syndrome, also known as Post-Covid-19 syndrome, is described as
Status | Completed |
Enrollment | 44 |
Est. completion date | August 4, 2023 |
Est. primary completion date | March 9, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion criteria: - Covid - be between 18-45 years old - Having pulmonary involvement in the covid process Exclusion criteria: - Being a professional in any sport - Having a cardiopulmonary, orthopedic, neurological and metabolic disease |
Country | Name | City | State |
---|---|---|---|
Turkey | Bahçesehir University | Istanbul | Istanbul Avrupa Kitasi |
Lead Sponsor | Collaborator |
---|---|
Istanbul Medipol University Hospital |
Turkey,
McNarry MA, Berg RMG, Shelley J, Hudson J, Saynor ZL, Duckers J, Lewis K, Davies GA, Mackintosh KA. Inspiratory muscle training enhances recovery post-COVID-19: a randomised controlled trial. Eur Respir J. 2022 Oct 6;60(4):2103101. doi: 10.1183/13993003.03101-2021. Print 2022 Oct. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Visual Analogue Scale (VAS) | In the measurement of pain intensity, it was planned to use a standard, 10 mm VAS with proven reliability. The severity of pain felt by the patient; It is a scale used to mark 0 = no pain and 10 = the most severe pain, thus determining the patient's pain intensity subjectively. | a day | |
Primary | Autonomic nervous system device (Polar H10) | The Polar H10 device is a heart rate sensor that comes with a wearable chest strap and is the gold standard of high sensitivity and accuracy. It can be connected to multiple training devices via Bluetooth and ANT+. The device comes with a soft, adjustable sensor that touches the chest to capture the heart rate in real time.
In the study, the autonomic nervous system will be evaluated with the Polar H10 device. By connecting the device to a smart phone via bluetooth, the data will be recorded and the software supported by the device will be used for the analysis of the data. |
a day | |
Primary | Lactate Analysis | It was measured with a portable lactate analyzer before and after exercise training, just before the recovery phase. It is an ideal lactate analyzer for using metabolic information to assess endurance, design optimal training programs, avoid overtraining plans and help identify target heart rate zones. | one day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06073002 -
Effects of a Home-Based Exercise Intervention in Subjects With Long COVID
|
N/A | |
Completed |
NCT05047952 -
Vortioxetine for Post-COVID-19 Condition
|
Phase 2 | |
Completed |
NCT05812209 -
Stellate Ganglion Block to Treat Long COVID 19 Case Series
|
||
Recruiting |
NCT06091384 -
Inspiratory Muscle Strength Training in Post-Covid Syndrome
|
N/A | |
Not yet recruiting |
NCT06267300 -
Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial
|
Phase 3 | |
Recruiting |
NCT05986422 -
Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS)
|
Phase 2 | |
Not yet recruiting |
NCT05534997 -
Rehabilitation Therapy for Post COVID 19 Chronic Fatigue Syndrome
|
N/A | |
Recruiting |
NCT05638633 -
Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
|
Phase 3 | |
Active, not recruiting |
NCT05630040 -
VNS for Long-COVID-19
|
N/A | |
Recruiting |
NCT05841498 -
Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome
|
N/A | |
Enrolling by invitation |
NCT05981872 -
EFFECT OF COGNITIVE BEHAVIORAL THERAPY ON DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH POST COVID-19
|
N/A | |
Active, not recruiting |
NCT05543408 -
Long COVID-19 Syndrome in Primary Care: A Novel Protocol of Exercise Intervention "CON-VIDA Clinical Trial"
|
N/A | |
Recruiting |
NCT05817032 -
Effect of Telerehabilitation Practice in Long COVID-19 Patients
|
N/A | |
Recruiting |
NCT05823896 -
imPROving Quality of LIFe In the Long COVID Patient
|
Phase 2 | |
Completed |
NCT05765591 -
Balneotherapy for Patients With Post-acute Coronavirus Disease (COVID) Syndrome
|
N/A | |
Recruiting |
NCT05918965 -
Vagus Stimulation in Female Long COVID Patients.
|
N/A | |
Not yet recruiting |
NCT06231238 -
Balance Acceptance and Commitment Therapy for Long COVID
|
Phase 2 | |
Completed |
NCT06282627 -
The COVID HOME Study: Prospective Cohort Study of Non-hospitalised COVID-19 Patients
|
||
Completed |
NCT05648734 -
Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis
|
||
Active, not recruiting |
NCT05753202 -
tDCS in Post-COVID Syndrome: Comparison of Two Targets
|
N/A |